Cargando…

Bioactive Compounds with Antiglioma Activity from Marine Species

The search for new chemical compounds with antitumor pharmacological activity is a necessary process for creating more effective drugs for each specific malignancy type. This review presents the outcomes of screening studies of natural compounds with high anti-glioma activity. Despite significant ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Khotimchenko, Rodion, Bryukhovetskiy, Igor, Khotimchenko, Maksim, Khotimchenko, Yuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389718/
https://www.ncbi.nlm.nih.gov/pubmed/34440090
http://dx.doi.org/10.3390/biomedicines9080886
_version_ 1783742924049088512
author Khotimchenko, Rodion
Bryukhovetskiy, Igor
Khotimchenko, Maksim
Khotimchenko, Yuri
author_facet Khotimchenko, Rodion
Bryukhovetskiy, Igor
Khotimchenko, Maksim
Khotimchenko, Yuri
author_sort Khotimchenko, Rodion
collection PubMed
description The search for new chemical compounds with antitumor pharmacological activity is a necessary process for creating more effective drugs for each specific malignancy type. This review presents the outcomes of screening studies of natural compounds with high anti-glioma activity. Despite significant advances in cancer therapy, there are still some tumors currently considered completely incurable including brain gliomas. This review covers the main problems of the glioma chemotherapy including drug resistance, side effects of common anti-glioma drugs, and genetic diversity of brain tumors. The main emphasis is made on the characterization of natural compounds isolated from marine organisms because taxonomic diversity of organisms in seawaters significantly exceeds that of terrestrial species. Thus, we should expect greater chemical diversity of marine compounds and greater likelihood of finding effective molecules with antiglioma activity. The review covers at least 15 classes of organic compounds with their chemical formulas provided as well as semi-inhibitory concentrations, mechanisms of action, and pharmacokinetic profiles. In conclusion, the analysis of the taxonomic diversity of marine species containing bioactives with antiglioma activity is performed noting cytotoxicity indicators and to the tumor cells in comparison with similar indicators of antitumor agents approved for clinical use as antiglioblastoma chemotherapeutics.
format Online
Article
Text
id pubmed-8389718
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83897182021-08-27 Bioactive Compounds with Antiglioma Activity from Marine Species Khotimchenko, Rodion Bryukhovetskiy, Igor Khotimchenko, Maksim Khotimchenko, Yuri Biomedicines Review The search for new chemical compounds with antitumor pharmacological activity is a necessary process for creating more effective drugs for each specific malignancy type. This review presents the outcomes of screening studies of natural compounds with high anti-glioma activity. Despite significant advances in cancer therapy, there are still some tumors currently considered completely incurable including brain gliomas. This review covers the main problems of the glioma chemotherapy including drug resistance, side effects of common anti-glioma drugs, and genetic diversity of brain tumors. The main emphasis is made on the characterization of natural compounds isolated from marine organisms because taxonomic diversity of organisms in seawaters significantly exceeds that of terrestrial species. Thus, we should expect greater chemical diversity of marine compounds and greater likelihood of finding effective molecules with antiglioma activity. The review covers at least 15 classes of organic compounds with their chemical formulas provided as well as semi-inhibitory concentrations, mechanisms of action, and pharmacokinetic profiles. In conclusion, the analysis of the taxonomic diversity of marine species containing bioactives with antiglioma activity is performed noting cytotoxicity indicators and to the tumor cells in comparison with similar indicators of antitumor agents approved for clinical use as antiglioblastoma chemotherapeutics. MDPI 2021-07-25 /pmc/articles/PMC8389718/ /pubmed/34440090 http://dx.doi.org/10.3390/biomedicines9080886 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Khotimchenko, Rodion
Bryukhovetskiy, Igor
Khotimchenko, Maksim
Khotimchenko, Yuri
Bioactive Compounds with Antiglioma Activity from Marine Species
title Bioactive Compounds with Antiglioma Activity from Marine Species
title_full Bioactive Compounds with Antiglioma Activity from Marine Species
title_fullStr Bioactive Compounds with Antiglioma Activity from Marine Species
title_full_unstemmed Bioactive Compounds with Antiglioma Activity from Marine Species
title_short Bioactive Compounds with Antiglioma Activity from Marine Species
title_sort bioactive compounds with antiglioma activity from marine species
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389718/
https://www.ncbi.nlm.nih.gov/pubmed/34440090
http://dx.doi.org/10.3390/biomedicines9080886
work_keys_str_mv AT khotimchenkorodion bioactivecompoundswithantigliomaactivityfrommarinespecies
AT bryukhovetskiyigor bioactivecompoundswithantigliomaactivityfrommarinespecies
AT khotimchenkomaksim bioactivecompoundswithantigliomaactivityfrommarinespecies
AT khotimchenkoyuri bioactivecompoundswithantigliomaactivityfrommarinespecies